Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NEXL -- Ignore unavailable to you. Want to Upgrade?

To: Kashmir who wrote (1340)	4/8/1998 10:00:00 AM
From: Mike Grove	Read Replies (1) \| Respond to of 1704

Kashmir, Thanks, that is what I thought. After some thought I think I'd rather own the stock of the individual companies .vs. VMRX. It appears that VMRX could go away very quickly leaving no trail other than debt and pissed off investors. If I understand the business plan, God knows, I certainly might be missing the boat on this, VMRX has invested in INVR and others in very specific R&D areas. That is, INVR could find the cure to the common cold and INVR's stock goes through the roof. However, since VMRX invested in the Cell therapy area VMRX would see no gains. True????? MG